title: [Severe mitral valve regurgitation in terminal heart failure: news beyond guidelines].
authors.affiliation: Innere Medizin III, Kardiologie, Angiologie und Pneumologie, Universitätsklinikum Heidelberg. sven.pleger@med.uni-heidelberg.de
authors.forename: S T
authors.initials: ST
authors.lastname: Pleger
authors.forename: H A
authors.initials: HA
authors.lastname: Katus
authors.forename: R
authors.initials: R
authors.lastname: Bekeredjian
mesh_terms: D058406:Cardiac Resynchronization Therapy; D002317:Cardiovascular Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D017548:Echocardiography, Transesophageal; D006333:Heart Failure / Q000401:mortality / Q000503:physiopathology* / Q000601:surgery*; D019918:Heart Valve Prosthesis Implantation / Q000401:mortality; D006801:Humans; D008943:Mitral Valve / Q000503:physiopathology / Q000601:surgery; D008944:Mitral Valve Insufficiency / Q000401:mortality / Q000503:physiopathology* / Q000601:surgery*; D062645:Percutaneous Coronary Intervention; D011183:Postoperative Complications / Q000401:mortality; D017410:Practice Guidelines as Topic; D011379:Prognosis; D012307:Risk Factors; D013525:Surgical Instruments; D015996:Survival Rate; D018487:Ventricular Dysfunction, Left / Q000401:mortality / Q000503:physiopathology / Q000601:surgery
chemical_list: D002317:Cardiovascular Agents